Skip to main content

Advertisement

SpringerLink
Log in

The Role of Safety-Net Hospitals in Reducing Disparities in Breast Cancer Care

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Advances in breast cancer screening and systemic therapies have been credited with profound improvements in breast cancer outcomes; indeed, 5-year relative survival rate approaches 91% in the USA (U.S. National Institutes of Health NCI. SEER Training Modules, Breast). While breast cancer mortality has been declining, oncologic outcomes have not improved equally among all races and ethnicities. Many factors have been implicated in breast cancer disparities; chief among them is limited access to care which contributes to lower rates of timely screening mammography and, once diagnosed with breast cancer, lower rates of receipt of guideline concordant care (Wu, Lund, Kimmick GG et al. in J Clin Oncol 30(2):142–150, 2012). Hospitals with a safety-net mission, such as the essential hospitals, historically have been dedicated to providing high-quality care to all populations and have eagerly embraced the role of caring for the most vulnerable and working to eliminate health disparities. In this article, we review landmark articles that have evaluated the role safety-net hospitals have played in providing equitable breast cancer care including to those patients who face significant social and economic challenges.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. U.S. National Institutes of Health NCI. SEER Training Modules, Breast.

  2. Wu X-C, Lund MJ, Kimmick GG, et al. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol. 2012;30:142–50.

    Article  PubMed  Google Scholar 

  3. Semega J, Kollar M, Creamer J, Mohanty A. Income and poverty in the United States: 2018. US Census Bureau. 2019.

  4. Shrider E KM, Chen F, Semega J. Income and poverty in the united states: 2020. US Census Bureau, Current Population Reports. 2021:60-273

  5. Brunch KK-SaLN. Health insurance coverage in the United States: 2020. US Census Bureau Current Population Reports. 2021:60-274.

  6. Retrieved 15 March 2021 at https://essentialhospitals.org/wp-content/uploads/2021/05/EssentialData2021 Web.pdf.

  7. Association AH. 2019 AHA Annual Survey. Health Forum LLC. 2020.

  8. Essential Data, Our Hospitals, Our Patients: Results of America’s Essential Hospitals 2018 Annual Member Characteristics Survey. Retrieved 12 February 2022 at https://essentialhospitals.org/wp-content/uploads/2021/05/EssentialData2021_Web.pdf. Published 2021.

  9. U.S. Census Bureau. Poverty Status in the Past 12 Months. 2020.

  10. U.S. Census Bureau. Selected Characteristics of the Uninsured in the United States. 2020.

  11. Development USDoHaU. 2019 AHAR: Part 1—PIT Estimates of Homelessness in the U.S. 2020.

  12. U.S. Department of Agriculture. Food Access Research Atlas Data Download 2015. 2017.

  13. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006;24:1342–9.

    Article  PubMed  Google Scholar 

  14. Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer. 2000;88:114–23.

    Article  CAS  PubMed  Google Scholar 

  15. Ooi SL, Martinez ME, Li CI. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat. 2011;127:729–38.

    Article  PubMed  Google Scholar 

  16. Chu KC, Lamar CA, Freeman HP. Racial disparities in breast carcinoma survival rates: seperating factors that affect diagnosis from factors that affect treatment. Cancer. 2003;97:2853–60.

    Article  PubMed  Google Scholar 

  17. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294:1765–72.

    Article  CAS  PubMed  Google Scholar 

  18. Kantor O, Wang ML, Bertrand K, et al. Racial and socioeconomic disparities in breast cancer outcomes within the AJCC pathologic prognostic staging system. Ann Surg Oncol. 2021;28:585–6.

    Article  Google Scholar 

  19. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 1991;338:327–31.

    Article  CAS  PubMed  Google Scholar 

  20. Anderson SJ, Wapnir I, Dignam JJ, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J Clin Oncol. 2009;27:2466–73.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Obeng-Gyasi S, Tarver W, Carlos RC, Andersen BL. Allostatic load: a framework to understand breast cancer outcomes in black women. NPJ Breast Cancer. 2021;7:100.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Beckie TM. A systematic review of allostatic load, health, and health disparities. Biol Res Nurs. 2012;14:311–46.

    Article  PubMed  Google Scholar 

  23. Mathew A, Doorenbos AZ, Li H, Jang MK, Park CG, Bronas UG. Allostatic load in cancer: a systematic review and mini meta-analysis. Biol Res Nurs. 2021;23:341–61.

    Article  PubMed  Google Scholar 

  24. Antoni MH, Dhabhar FS. The impact of psychosocial stress and stress management on immune responses in patients with cancer. Cancer. 2019;125:1417–31.

    Article  PubMed  Google Scholar 

  25. Berrian JL, Liu Y, Lian M, Schmaltz CL, Colditz GA. Relationship between insurance status and outcomes for patients with breast cancer in Missouri. Cancer. 2021;127:931–7.

    Article  PubMed  Google Scholar 

  26. Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med. 1993;329:326–31.

    Article  CAS  PubMed  Google Scholar 

  27. Pan HY, Walker GV, Grant SR, et al. Insurance status and racial disparities in cancer-specific mortality in the United States: a population-based analysis. Cancer Epidemiol Biomarkers Prev. 2017;26:869–75.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Samiian L, Sharma P, Van Den Bruele AB, Smotherman C, Vincent M, Crandall M. The effect of insurance and race on breast cancer tumor biology and short-term outcomes. Am Surg. 2018;84:1223–8.

    Article  PubMed  Google Scholar 

  29. US Census Bureau. 2013–2017 American Community Survey 5-Year Estimates.

  30. Gilligan MA, Kneusel RT, Hoffmann RG, Greer AL, Nattinger AB. Persistent differences in sociodemographic determinants of breast-conserving treatment despite overall increased adoption. Med Care. 2002;40:181–9.

    Article  PubMed  Google Scholar 

  31. Albano JD, Ward E, Jemal A, et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst. 2007;99:1384–94.

    Article  PubMed  Google Scholar 

  32. Byers TE, Wolf HJ, Bauer KR, et al. The impact of socioeconomic status on survival after cancer in the United States. Cancer. 2008;113:582–91.

    Article  PubMed  Google Scholar 

  33. Sprague BL, Trentham-Dietz A, Gangnon RE, et al. Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer. 2011;117:1542–51.

    Article  PubMed  Google Scholar 

  34. Dreyer MS, Nattinger AB, McGinley EL, Pezzin LE. Socioeconomic status and breast cancer treatment. Breast Cancer Res Treat. 2018;167:1–8.

    Article  PubMed  Google Scholar 

  35. Wheeler SB, Spencer J, Pinheiro LC, et al. Endocrine therapy nonadherence and discontinuation in black and white women. JNCI. 2018;111:498–508.

    Article  PubMed Central  Google Scholar 

  36. Wheeler SB, Kohler RE, Reeder-Hayes KE, et al. Endocrine therapy initiation among Medicaid-insured breast cancer survivors with hormone receptor-positive tumors. J Cancer Surviv. 2014;8:603–10.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Spencer JC, Reeve BB, Troester MA, Wheeler SB. Factors associated with endocrine therapy non-adherence in breast cancer survivors. Psycho-oncology. 2020;29:647–54.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Collaborative G, Davies C, Godwin J, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378:771–84.

    Article  CAS  Google Scholar 

  39. Baggett TP, Chang Y, Porneala BC, Bharel M, Singer DE, Rigotti NA. Disparities in cancer incidence, stage, and mortality at boston health care for the homeless Program. Am J Prev Med. 2015;49:694–702.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Asgary R, Garland V, Sckell B. Breast cancer screening among homeless women of New York City shelter-based clinics. Women’s Health Issues. 2014;24:529–34.

    Article  PubMed  Google Scholar 

  41. Kosog K, Earle M, Stellon E, et al. Identifying an association between socio-demographic factors and breast cancer screening adherence in a federally qualified health centre sample in the United States: a retrospective, cross-sectional study. Health Social Care Commun. 2020;28:1772–9.

    Article  Google Scholar 

  42. Gehlert SJ, Polite BN, Grushko TA, et al. Social, biological, and tumor characteristics of 139 African American (AA) women with newly diagnosed breast cancer in Chicago. J Clin Oncol. 2010;28(15 Suppl):6064–6064.

    Article  Google Scholar 

  43. Jetelina KK, Carr C, Murphy CC, Sadeghi N, Lea S, Tiro JA. The impact of intimate partner violence on breast and cervical cancer survivors in an integrated, safety-net setting. J Cancer Survivorship. 2020;14:906–14.

    Article  Google Scholar 

  44. Breiding MJ, Smith SG, Basile KC, Walters ML, Chen J, Merrick MT. Prevalence and characteristics of sexual violence, stalking, and intimate partner violence victimization: national intimate partner and sexual violence survey, United States, 2011. MMWR Surveill Summ. 2014;63:1–18.

    PubMed  Google Scholar 

  45. Black MC BK, Breiding MJ, Smith SG, Walters ML, Merrick MT. The National Intimate Partner and Sexual Violence Survey (NISVS): 2010 Summary Report. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, 2011.

  46. National Comprehesive Cancer Network. Breast Cancer, version 3.2019. 2019.

  47. Cancer Prevention & Early Detection Facts & Figures 2019–2020. American Cancer Society, 2019.

  48. Allgood KL, Rauscher GH, Whitman S, Vasquez-Jones G, Shah AM. Validating self-reported mammography use in vulnerable communities: findings and recommendations. Cancer Epidemiol Biomarkers Prev. 2014;23:1649–58.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Cronin KA, Miglioretti DL, Krapcho M, et al. Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev. 2009;18:1699–705.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Molina Y, Silva A, Rauscher GH. Racial/ethnic disparities in time to a breast cancer diagnosis: the mediating effects of healthcare facility factors. Med Care. 2015;53:872–8.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Miller-Kleinhenz JM, Collin LJ, Seidel R, et al. Racial disparities in diagnostic delay among women with breast cancer. J Am Coll Radiol. 2021;18:1384–93.

    Article  PubMed  Google Scholar 

  52. Rauscher GH, Allgood KL, Whitman S, Conant E. Disparities in screening mammography services by race/ethnicity and health insurance. J Women’s Health. 2002;2012(21):154–60.

    Google Scholar 

  53. Group UCSW. United States Cancer Statistics: 1999–2013 Incidence and Mortality Web-Based Report. In US Dept of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, 2016.

  54. DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66:31–42.

    Article  PubMed  Google Scholar 

  55. Kohler BA, Sherman RL, Howlader N, et al. Annual report to the nation on the status of cancer, featuring incidence of breast cancer subtypes by race ethnicity, poverty, and state. J Natl Cancer Inst. 2015;107:djv048.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  56. Friebel-Klingner TM, Ehsan S, Conant EF, Kontos D, Domchek SM, McCarthy AM. Risk factors for breast cancer subtypes among black women undergoing screening mammography. Breast Cancer Res Treat. 2021;189(3):827–35.

    Article  CAS  PubMed  Google Scholar 

  57. Daly MB PR, Berry M. National Comprehensive Cancer Network Guidelines: Genetic/Familial High-Risk Assessment: Breast and Ovarian, version 3.2019.

  58. Huang H, Apouey B, Andrews J. Racial and ethnic disparities in awareness of cancer genetic testing among online users: internet use, health knowledge, and socio-demographic correlates. J Cons Health Internet. 2014;18:15–30.

    Article  Google Scholar 

  59. Hamilton JG, Shuk E, Arniella G, et al. Genetic testing awareness and attitudes among latinos: exploring shared perceptions and gender-based differences. Public Health Genomics. 2016;19:34–46.

    Article  PubMed  Google Scholar 

  60. Churpek JE, Walsh T, Zheng Y, et al. Inherited predisposition to breast cancer among African American women. Breast Cancer Res Treat. 2015;149:31–9.

    Article  CAS  PubMed  Google Scholar 

  61. Chalela P, Pagan JA, Su D, Munoz E, Ramirez AG. Breast cancer genetic testing awareness, attitudes and intentions of Latinas living along the US-Mexico border: a qualitative study. J Community Med Health Educ. 2012;2

  62. Cragun D, Weidner A, Kechik J, Pal T. Genetic testing across young Hispanic and non-Hispanic white breast cancer survivors: facilitators, barriers, and awareness of the Genetic Information Nondiscrimination Act. Genet Test Mol Biomarkers. 2019;23:75–83.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Hann KEJ, Freeman M, Fraser L, et al. Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review. BMC Public Health. 2017;17:503.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Adams I, Christopher J, Williams KP, Sheppard VB. What black women know and want to know about counseling and testing for BRCA1/2. J Cancer Educ. 2015;30:344–52.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Jones T, McCarthy AM, Kim Y, Armstrong K. Predictors of BRCA1/2 genetic testing among black women with breast cancer: a population-based study. Cancer Med. 2017;6:1787–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Steffen LE, Du R, Gammon A, et al. Genetic testing in a population-based sample of breast and ovarian cancer survivors from the REACH randomized trial: cost barriers and moderators of counseling mode. Cancer Epidemiol Biomarkers Prev. 2017;26:1772–80.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Hong YA, Cho J. Has the digital health divide widened? Trends of health-related internet use among older adults from 2003 to 2011. J Gerontol Series B Psychol Sci Soc Sci. 2017;72:856–63.

    Google Scholar 

  68. Tutt A, Garber JE, Kaufman B, et al. OlympiA: a phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancer. J Clin Oncol. 2021;39(18 Suppl):LBA1–LBA1.

  69. Tseng JF, Kronowitz SJ, Sun CC, et al. The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer. 2004;101:1514–23.

    Article  PubMed  Google Scholar 

  70. Kruper L, Holt A, Xu XX, et al. Disparities in reconstruction rates after mastectomy: patterns of care and factors associated with the use of breast reconstruction in Southern California. Ann Surg Oncol. 2011;18:2158–65.

    Article  PubMed  Google Scholar 

  71. Shippee TP, Kozhimannil KB, Rowan K, Virnig BA. Health insurance coverage and racial disparities in breast reconstruction after mastectomy. Women’s Health Issues. 2014;24:e261-9.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Butler PD, Nelson JA, Fischer JP, et al. Racial and age disparities persist in immediate breast reconstruction: an updated analysis of 48,564 patients from the 2005 to 2011 American College of Surgeons National Surgery Quality Improvement Program data sets. Am J Surg. 2016;212:96–101.

    Article  PubMed  Google Scholar 

  73. Rubin LR, Chavez J, Alderman A, Pusic AL. Use what God has given me: difference and disparity in breast reconstruction. Psychol Health. 2013;28:1099–120.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Schumacher JR, Taylor LJ, Tucholka JL, et al. Socioeconomic factors associated with post-mastectomy immediate reconstruction in a contemporary cohort of breast cancer survivors. Ann Surg Oncol. 2017;24:3017–23.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Marin G, Sabogal F, Marin BV, Otero-Sabogal R, Perez-Stable EJ. Development of a short acculturation scale for Hispanics. Hispanic J Behav Sci. 1987;9:183–205.

    Article  Google Scholar 

  76. Alderman AK, Hawley ST, Janz NK, et al. Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population- based study. J Clin Oncol. 2009;27:5325–30.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Morrow M, Li Y, Alderman AK, et al. Access to breast reconstruction after mastectomy and patient perspectives on reconstruction decision making. JAMA Surg. 2014;149:1015–21.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Morrow M, Mujahid M, Lantz PM, et al. Correlates of breast reconstruction: results from a population-based study. Cancer. 2005;104:2340–6.

    Article  PubMed  Google Scholar 

  79. Chen MS Jr, Lara PN, Dang JH, Paterniti DA, Kelly K. Twenty years post-NIH revitalization act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials. Cancer. 2014;120(Suppl 7):1091–6.

    Article  PubMed  Google Scholar 

  80. Smith CE, Fullerton SM, Dookeran KA, et al. Using genetic technologies to reduce, rather than widen, health disparities. Health Aff Millwood. 2016;35:1367–73.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Coakley M, Fadiran EO, Parrish LJ, Griffith RA, Weiss E, Carter C. Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials. J Women’s Health. 2002;2012(21):713–6.

    Google Scholar 

  82. Niranjan SJ, Martin MY, Fouad MN, et al. Bias and stereotyping among research and clinical professionals: perspectives on minority recruitment for oncology clinical trials. Cancer. 2020;126:1958–68.

    Article  PubMed  Google Scholar 

  83. Heller C, Balls-Berry JE, Nery JD, et al. Strategies addressing barriers to clinical trial enrollment of underrepresented populations: a systematic review. Contemp Clin Trials. 2014;39:169–82.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Meropol NJ, Wong YN, Albrecht T, et al. Randomized trial of a Web-based intervention to address barriers to clinical trials. J Clin Oncol. 2016;34:469–78.

    Article  PubMed  Google Scholar 

  85. Janson SL, Alioto ME, Boushey HA. Attrition and retention of ethnically diverse subjects in a multicenter randomized controlled research trial. Control Clin Trials. 2001;22(6 Suppl):236s–43s.

    Article  CAS  PubMed  Google Scholar 

  86. Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract. 1995;3:19–30.

    CAS  PubMed  Google Scholar 

  87. Frelix GD, Rosenblatt R, Solomon M, Vikram B. Breast cancer screening in underserved women in the Bronx. J Natl Med Assoc. 1999;91:195–200.

    CAS  PubMed  PubMed Central  Google Scholar 

  88. Ell K, Padgett D, Vourlekis B, et al. Abnormal mammogram follow-up: a pilot study women with low income. Cancer Pract. 2002;10:130–8.

    Article  PubMed  Google Scholar 

  89. Dohan D, Schrag D. Using navigators to improve care of underserved patients. Cancer. 2005;104:848–55.

    Article  PubMed  Google Scholar 

  90. Asgary R, Naderi R, Wisnivesky J. Opt-out patient navigation to improve breast and cervical cancer screening among homeless women. J Women’s Health. 2002;2017(26):999–1003.

    Google Scholar 

  91. New York State Department of Health. Legislation to Improve Coverage for Breast Cancer Screening January 1, 2017. Retrieved 2 March 2020 at https://www.health.ny.gov/diseases/cancer/breast/nys_breast_cancer_faqs.htm.

  92. New York State Department of Health. About New York State’s New Breast Cancer Programs.

  93. New York State Department of Health. New York State Cancer Services Program.

  94. Green AK, Aviki EM, Matsoukas K, Patil S, Korenstein D, Blinder V. Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2018;172:247–63.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Du Xianglin L, Gor BJ. Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis. 2007;17:122–8.

    PubMed  Google Scholar 

  96. Tang A, Mooney CM, Beattie G, et al. Health equity within inequity: timing of diagnostic breast cancer care in an underserved medical population. Anticancer Res. 2021;41:3607–13.

    Article  PubMed  Google Scholar 

  97. Lalchandani P, Sila C, Ozao-Choy J, Dauphine C. Initiation of an intraoperative radiotherapy program at a safety-net hospital: what is the impact of an intraoperative radiotherapy program in underserved patients with early breast cancer? Am Surg. 2021;87:833–8.

    Article  PubMed  Google Scholar 

  98. Alexander D, Schnell M. The impacts of physician payments on patient access, use, and health. National Bureau of Economic Research Working Paper Series. 2019;26095.

  99. Sarkar RR, Courtney PT, Bachand K, et al. Quality of care at safety-net hospitals and the impact on pay-for-performance reimbursement. Cancer. 2020;126:4584–92.

    Article  PubMed  Google Scholar 

  100. Hsu HE, Wang R, Broadwell C, et al. Association between federal value-based incentive programs and health care-associated infection rates in safety-net and non–safety-net hospitals. JAMA Netwk Open. 2020;3:e209700–e209700.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Surgery, True Family Women’s Cancer Center, Swedish Cancer Institute, Seattle, WA, USA

    Angelena Crown MD

  2. America’s Essential Hospitals, Washington, DC, USA

    Kalpana Ramiah DrPH, MSc & Bruce Siegel MD, MPH

  3. Department of Surgery, New York University School of Medicine, NYC Health and Hospitals, Bellevue, New York, NY, USA

    Kathie-Ann Joseph MD, MPH

Authors
  1. Angelena Crown MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kalpana Ramiah DrPH, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bruce Siegel MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kathie-Ann Joseph MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kathie-Ann Joseph MD, MPH.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Crown, A., Ramiah, K., Siegel, B. et al. The Role of Safety-Net Hospitals in Reducing Disparities in Breast Cancer Care. Ann Surg Oncol 29, 4067–4075 (2022). https://doi.org/10.1245/s10434-022-11576-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-11576-3

Search

Navigation